Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetically variable metabolism of antidepressants and neuroleptic drugs in man.

× No keyword cloud information.

28 in total

1. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation.

Authors: K J Aitchison; J Munro; P Wright; S Smith; A J Makoff; C Sachse; P C Sham; R M Murray; D A Collier; R W Kerwin
Journal: Br J Clin Pharmacol Date: 1999-09 Impact factor: 4.335

2. Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring.

Authors: Y Merlé; F Mentré
Journal: J Pharmacokinet Biopharm Date: 1999-02

Review 3. Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors: Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal: Clin Pharmacokinet Date: 2004 Impact factor: 6.447

4. Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report.

Authors: Maximilian Gahr; Regina Gastl; Markus A Kölle; Carlos Schönfeldt-Lecuona; Roland W Freudenmann
Journal: J Med Case Rep Date: 2012-02-06

Review 5. Pharmacogenomics: challenges and opportunities.

Authors: Dan M Roden; Russ B Altman; Neal L Benowitz; David A Flockhart; Kathleen M Giacomini; Julie A Johnson; Ronald M Krauss; Howard L McLeod; Mark J Ratain; Mary V Relling; Huijun Z Ring; Alan R Shuldiner; Richard M Weinshilboum; Scott T Weiss
Journal: Ann Intern Med Date: 2006-11-21 Impact factor: 25.391

6. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.

Authors: E Spina; C Gitto; A Avenoso; G M Campo; A P Caputi; E Perucca
Journal: Eur J Clin Pharmacol Date: 1997 Impact factor: 2.953

Review 7. Assessment of liver metabolic function. Clinical implications.

Authors: J Brockmöller; I Roots
Journal: Clin Pharmacokinet Date: 1994-09 Impact factor: 6.447

Review 8. Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype.

Authors: A Llerena; J Cobaleda; C Martínez; J Benítez
Journal: Eur J Drug Metab Pharmacokinet Date: 1996 Apr-Jun Impact factor: 2.441

Review 9. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

Authors: O Spigset; K Hedenmalm
Journal: Drug Saf Date: 1995-03 Impact factor: 5.606

10. The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.

Authors: K Chiba; A Saitoh; E Koyama; M Tani; M Hayashi; T Ishizaki
Journal: Br J Clin Pharmacol Date: 1994-03 Impact factor: 4.335